Local infiltration for postsurgical analgesia following total hip arthroplasty: a comparison of liposomal bupivacaine to traditional bupivacaine

References

• Centers for Disease Control and Prevention. Number of all-listed procedures for discharges from short-stay hospitals, by procedure category and age: United States, 2010. Centers for Disease Control and Prevention website. Available at: http://www.cdc.gov/nchs/data/nhds/4procedures/2010pro4_numberprocedureage.pdf [Last accessed 21 July 2016]
   Google Scholar
• Cross M, Smith E, Hoy D, et al. The global burden of hip and knee osteoarthritis: estimates from the global burden of disease 2010 study. Ann Rheum Dis 2014;73:1323-30
   PubMed Web of Science ®Google Scholar
• Kurtz S, Ong K, Lau E, et al. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am 2007;89:780-5
   PubMed Web of Science ®Google Scholar
• Cherian JJ, Barrington J, Elmallah RK, et al. Liposomal bupivacaine suspension, can reduce length of stay and improve discharge status of patients undergoing total hip arthroplasty. Surg Technol Int 2015;27:235-39
   PubMedGoogle Scholar
• Barrington JW, Halaszynski TM, Sinatra RS; for the Expert Working Group on Anesthesia and Orthopaedics: Critical Issues in Hip and Knee Replacement Arthroplasty. Perioperative pain management in hip and knee replacement surgery. Am J Orthop 2014;43:S1-S16
   PubMedGoogle Scholar
• Barrington JW, Dalury DF, Emerson RH Jr, et al. Improving patient outcomes through advanced pain management techniques in total hip and knee arthroplasty. Am J Orthoped 2013;42:S1-S17
   PubMedGoogle Scholar
• Hojer Karlsen AP, Geisler A, Petersen PL, et al. Postoperative pain treatment after total hip arthroplasty: a systematic review. Pain 2015;156:8-30
   PubMed Web of Science ®Google Scholar
• American Society of Anesthesiologists Task Force on Acute Pain Management. Practice guidelines for acute pain management in the perioperative setting: an updated report by the American Society of Anesthesiologists Task Force on Acute Pain Management. Anesthesiology 2012;116:248-73
   PubMed Web of Science ®Google Scholar
• Raiff D, Vaughan C, McGee A. Impact of intraoperative acetaminophen administration on postoperative opioid consumption in patients undergoing hip or knee replacement. Hosp Pharm 2014;49:1022-32
   PubMedGoogle Scholar
• Husted H, Lunn TH, Troelsen A, et al. Why still in hospital after fast-track hip and knee arthroplasty? Acta Orthop 2011;82:679-84
   PubMed Web of Science ®Google Scholar
• Centers for Medicare & Medicaid Services. HCAHPS: Patients’ Perspectives of Care Survey. Available at: https://www.cms.gov/Medicare/Quality-Initiatives-patient-assessment-instruments/hospitalqualityinits/hospitalhcahps.html [Last accessed 21 July 2016]
   Google Scholar
• Centers for Medicare & Medicaid Services. Medicare program; hospital inpatient value-based purchasing program. Final rule. Fed Regist 2011;76:26490-547
   PubMedGoogle Scholar
• Centers for Medicare & Medicaid Services. HCAHPS Survey. Available at: http://www.hcahpsonline.org/files/March%202016_Survey%20Instruments_English_Mail.pdf [Last accessed 13 September 2016]
   Google Scholar
• McCarthy D, Iohom G. Local infiltration analgesia for postoperative pain control following total hip arthroplasty: a systematic review. Anesthesiol Res Pract 2012;2012:709531
   PubMedGoogle Scholar
• Joshi GP, Beck DE, Emerson RH, et al. Defining new directions for more effective management of surgical pain in the United States: highlights of the Inaugural Surgical Pain Congress. Am Surg 2014;80:219-28
   PubMed Web of Science ®Google Scholar
• Jimenez-Almonte JH, Wyles CC, Wyles SP, et al. Is local infiltration analgesia superior to peripheral nerve blockade for pain management after THA: a network meta-analysis. Clin Orthop Relat Res 2016;474:495-516
   PubMed Web of Science ®Google Scholar
• Golembiewski J, Dasta J. Evolving role of local anesthetics in managing postsurgical analgesia. Clin Ther 2015;37:1354-71
   PubMed Web of Science ®Google Scholar
• Exparel [prescribing information]. Parsippany, NJ: Pacira Pharmaceuticals Inc., 2015
   Google Scholar
• Bergese SD, Ramamoorthy S, Patou G, et al. Efficacy profile of liposome bupivacaine, a novel formulation of bupivacaine for postsurgical analgesia. J Pain Res 2012;5:107-16
   PubMedGoogle Scholar
• Dasta J, Ramamoorthy S, Patou G, Sinatra R. Bupivacaine liposome injectable suspension compared with bupivacaine HCl for the reduction of opioid burden in the postsurgical setting. Curr Med Res Opin 2012;28:1609-15
   PubMed Web of Science ®Google Scholar
• Viscusi ER, Sinatra R, Onel E, Ramamoorthy SL. The safety of liposome bupivacaine, a novel local analgesic formulation. Clin J Pain 2014;30:102-10
   PubMed Web of Science ®Google Scholar
• Barrington JW, Olugbode O, Lovald S, et al. Liposomal bupivacaine: a comparative study of more than 1000 total joint arthroplasty cases. Orthop Clin North Am 2015;46:469-77
   PubMed Web of Science ®Google Scholar
• Kharitonov V. A review of the compatibility of liposome bupivacaine with other drug products and commonly used implant materials. Postgrad Med 2014;126:129-38
   PubMed Web of Science ®Google Scholar
• Crawford M, Church J, Akin B. CPI Detailed Report: Data for December 2015. Available at: http://www.bls.gov/cpi/cpid1512.pdf [Last accessed 10 November 2016]
   Google Scholar
• Medicare Acute Inpatient PPS FY 2013 Final Rule Data Files. Available at: https://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/AcuteInpatientPPS/Downloads/FY_13_FR_Impact_File.zip [Last accessed 10 November 2016]
   Google Scholar
• Kirkness CS, Asche CV, Ren J, et al. Assessment of liposome bupivacaine infiltration versus continuous femoral nerve block for postsurgical analgesia following total knee arthroplasty: a retrospective cohort study. Curr Med Res Opin 2016;32:1727-33
   PubMed Web of Science ®Google Scholar
• Domb BG, Gupta A, Hammarstedt JE, et al. The effect of liposomal bupivacaine injection during total hip arthroplasty: a controlled cohort study. BMC Musculoskelet Disord 2014;15:310
   PubMed Web of Science ®Google Scholar
• Springer BD. Transition from nerve blocks to periarticular injections and emerging techniques in total joint arthroplasty. Am J Orthop (Belle Mead NJ) 2014;43:S6-S9
   PubMedGoogle Scholar
• Lombardi AV Jr. Recent advances in incorporation of local analgesics in postsurgical pain pathways. Am J Orthop (Belle Mead NJ) 2014;43:S2-S5
   PubMedGoogle Scholar
• Emerson RH, Barrington JW, Olugbode O, et al. Comparison of local infiltration analgesia to bupivacaine wound infiltration as part of a multimodal pain program in total hip replacement. J Surg Orthop Adv 2015;24:235-41
   PubMedGoogle Scholar
• Yu SW, Szulc AL, Walton SL, et al. Liposomal bupivacaine as an adjunct to postoperative pain control in total hip arthroplasty. J Arthroplasty 2016;31:1510-15
   PubMed Web of Science ®Google Scholar
• Ramos NL, Karia RJ, Hutzler LH, et al. The effect of discharge disposition on 30-day readmission rates after total joint arthroplasty. J Arthroplasty 2014;29:674-7
   PubMed Web of Science ®Google Scholar
• Nichols CI, Vose JG. Clinical outcomes and costs within 90 days of primary or revision total joint arthroplasty. J Arthroplasty 2016;31:1400-6
   PubMed Web of Science ®Google Scholar
• Bozic KJ, Ward L, Vail TP, Maze M. Bundled payments in total joint arthroplasty: targeting opportunities for quality improvement and cost reduction. Clin Orthop Relat Res 2014;472:188-93
   PubMed Web of Science ®Google Scholar
• Centers for Medicare & Medicaid Services. Medicare program; Comprehensive Care for Joint Replacement payment model for acute care hospitals furnishing lower extremity joint replacement services. Final rule. Fed Regist 2015;80:73273-554
   PubMedGoogle Scholar
• Schairer WW, Sing DC, Vail TP, Bozic KJ. Causes and frequency of unplanned hospital readmission after total hip arthroplasty. Clin Orthop Relat Res 2014;472:464-70
   PubMed Web of Science ®Google Scholar
• Kurtz SM, Lau EC, Ong KL, et al. Hospital, patient, and clinical factors influence 30- and 90-day readmission after primary total hip arthroplasty. J Arthroplasty 2016;31:2130-8
   PubMed Web of Science ®Google Scholar